Commencement of equity-method accounting for メディアスソリューション・メディカルバイオサイエンス
First written in FY2019. 1 of 3 entries say "Reframed", first in FY2020. Latest entry: FY2022.
1 other company's latest entry also says "Restated".
- FY2022RestatedAnnual report
「8 consolidated subsidiaries (協和医科器械㈱, ㈱栗原医療器械店, ㈱ミタス, ㈱秋田医科器械店, ㈱アルバース, ㈱アクティブメディカル, 佐野器械㈱, メディアスソリューション㈱)」
メディアスソリューション continues to be classified as a consolidated subsidiary. - FY2020ReframedAnnual report
「メディアスソリューション㈱, which had previously been accounted for under the equity method, was included in the scope of consolidation from the current consolidated fiscal year because its significance increased.」
メディアスソリューション's accounting status changed from an unconsolidated subsidiary accounted for under the equity method to a consolidated subsidiary. - FY2019First statedAnnual report
「Although total assets and net sales of メディアスソリューション㈱ and ㈱メディカルバイオサイエンス do not have a material impact on the consolidated financial statements, the significance of their net income or loss increased, so they became unconsolidated subsidiaries accounted for under the equity method from the current consolidated fiscal year.」
The accounting status of the 2 companies changed to unconsolidated subsidiaries accounted for under the equity method from the current consolidated fiscal year because the significance of their net income or loss increased.